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Abstract
In 2019, the German Commission for the Investigation of Health Hazards of
Chemical Compounds in the Work Area has re-evaluated the BAT value of
N,N-dimethylacetamide [127-19‑5], following the re-evaluation of the MAK value.
The major routes of uptake of N,N-dimethylacetamide in the workplace are inhala-
tion and nearly 30% dermal absorption. Several studies indicated a non-linear corre-
lation between occupational exposure and urinary excretion of N‑methylacetamide.
An equation for the correlation between occupational exposure to N,N-dimethylacet-
amide in air and urinary excretion of N‑methylacetamide was reported, which is in
line with the results of field and human exposure studies. The equation does not con-
sider the additional dermal uptake of liquid N,N-dimethylacetamide. In correlation to
the MAK value of 5 mg N,N-dimethylacetamide/m3, a BAT value of 25 mg N‑methyl-
acetamide plus N‑hydroxymethyl-N-methylacetamide/l urine was established. Sam-
pling time is at the end of exposure or end of shift. Sampling time for long-term
exposures is at the end of the shift after several shifts.
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25 mg N‑methylacetamide plus N‑hydroxymethyl-
N-methylacetamide/l urine
BAT value (2019)
Sampling time: end of exposure or end of shift; for long-term expo-
sure: at the end of the shift after several shifts
MAK value (2017) 5 ml/m3 ≙ 18 mg/m3
Absorption through the skin (1969) H
Carcinogenicity –
Re-evaluation
For substances whose MAK value is based on systemic effects and was derived from animal inhalation studies
or studies involving volunteers at rest, the Commission has taken into account since 2016 that the respiratory
volume in the workplace is higher than under these experimental conditions (Hartwig and MAK Commission 2017).
However, this does not apply to gases and vapours if their blood:air partition coefficient is < 5 (see List of MAK
and BAT Values, DFG 2019). The blood:air partition coefficient for N,N-dimethylacetamide calculated according to
the formula developed by Buist et al. (2012) is 26 037. Taking into account the increased respiratory volume in the
workplace, the MAK value of N,N-dimethylacetamide was reduced from 10 ml/m3 to 5 ml/m3 (Hartwig and MAK
Commission 2019).
The dermal intake of N,N-dimethylacetamide in humans from the gas phase is particularly high. Consequently,
the concentration of the urinary metabolite N‑methylacetamide results from 70% inhalation and 30% percutaneous
(vapour) absorption of N,N-dimethylacetamide from the air (Maxfield et al. 1975). According to Nomiyama et al.
(2000), dermal absorption of vaporous N,N-dimethylacetamide accounts for about 40% of the N‑methylacetamide
excreted in urine.
Kennedy and Pruett (1989) as well as Borm et al. (1987) have described a non-linear relationship between the con-
centration of N,N-dimethylacetamide in air and N‑methylacetamide in urine. Kennedy (1990) derived from his data
(Kennedy and Pruett 1989) and the study by Borm et al. (1987) the following equation for the non-linear relationship





Table 1 shows the N‑methylacetamide concentrations in urine calculated according to Kennedy (1990) after end of
shift for N,N-dimethylacetamide concentrations in air of 1, 5 and 10 ml DMAC/m3.
Tab. 1 N,N-Dimethylacetamide concentrations in air and N-methylacetamide concentrations in urine after end of shift (calculation
according to Kennedy 1990)
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Based on the MAK value of 5 ml N,N-dimethylacetamide/m3 in air, the equation of Kennedy (1990) yields
a N-methylacetamide concentration in urine of 26 mg/l.
Hence, a BAT value of
25 mg N‑methylacetamide/l urine
is established. The sampling time is at the end of exposure or end of shift, for long-term exposures: at the end of
the shift after several shifts.
The BAT value relates to normally concentrated urine, in which the creatinine level should be in the range between
0.3 and 3 g/l. It is generally recommended that the measurement be repeated in normally hydrated subjects if urine
samples are outside the above-mentioned limits (Bader et al. 2016).
As already stated in the BAT addendum of 2010 (translated in Bader 2016), to determine the N‑methylacetamide
in urine, the sum of N‑methylacetamide and the dimethylacetamide metabolites N‑hydroxymethyl-N‑methyl-
acetamide are analysed using gas chromatography. In the injector of the gas chromatograph, N‑hydroxymethyl-
N‑methylacetamide cleaves off formaldehyde and forms N‑methylacetamide. The current BAT value accounts for
this reaction and is related to the sum of N‑methylacetamide excreted in urine and that formed in the injector
(Knecht and Müller 2003).
References
Bader M (2016) Addendum to N,N-dimethylacetamide. BATValue Documentation, 2010. MAKCollect Occup Health Saf. DOI: 10.1002/3527600418.
bb12719e1716
Bader M, Ochsmann E, Drexler H, Hartwig A, MAK Commsission (2016) Addendum to creatinine as reference parameter for the concentration of
substances in urine. BAT Value Documentation, 2010. MAK Collect Occup Health Saf 1: 266–268. DOI: 10.1002/3527600418.bbgeneral05e1715
Borm PJA, de Jong L, Vliegen A (1987) Environmental and biological monitoring of workers occupationally exposed to dimethylacetamide.
J Occup Med 29: 898–903
Buist HE, de Wit-Bos L, Bouwman T, Vaes WHJ (2012) Predicting blood:air partition coefficients using basic physicochemical properties. Regul
Toxicol Pharmacol 62: 23–28. DOI: 10.1016/j.yrtph.2011.11.019
DFG (Deutsche Forschungsgemeinschaft) (ed) (2019) List of MAK and BAT Values 2019, Permanent Senate Commission for the Investigation of
Health Hazards of Chemical Compounds in the Work Area, report 55. Wiley-VCH, Weinheim. DOI: 10.1002/9783527826889
Hartwig A, MAK Commission (2019) N,N-Dimethylacetamide. MAK Value Documentation, 2018. MAK Collect Occup Health Saf 4: 1321–1343.
DOI: 10.1002/3527600418.mb12719e6519
Hartwig A, MAK Commission (2017) Increased respiratory volume at the workplace – Significance for the derivation of the MAK value. MAK
Value Documentation, 2017. MAK Collect Occup Health Saf 2: 277–283. DOI: 10.1002/3527600418.mbrespivole6217
Kennedy GL, Pruett JW (1989) Biological monitoring for dimethylacetamide: measurement for 4 consecutive weeks in a workplace. J Occup Med
31: 47–50
Kennedy GL (1990) Biological monitoring in the American chemical industry. In: Fiserova-Bergerova V, Ogata M (eds) Biological monitoring of
exposure to industrial chemicals. ACGIH, Cincinnati, OH, 63–67
Knecht U, Müller G (2003) N,N-Dimethylacetamide (DMA) and N‑methylacetamide (NMA). Biomonitoring Method, 2003. In: Angerer J,
Schaller KH, Greim H (eds) Analyses of Hazardous Substances in Biological Materials, vol 8. Wiley-VCH, Weinheim, 67–83. Also available
from DOI: 10.1002/3527600418.bi12719e0008
Maxfield M, Barnes JR, Azar A, Trochimowicz H (1975) Urinary excretion of metabolite following experimental human exposures to DMF and
DMAC. J Occup Med 17: 506–511
Nomiyama T, Omae K, Ishizuka C, Yamauchi T, Kawasumi Y, Yamada K, Endoh H, Sakurai H (2000) Dermal absorption of N,N-dimethylacet-
amide in human volunteers. Int Arch Occup Environ Health 73: 121–126. DOI: 10.1007/s004200050017
The MAK Collection for Occupational Health and Safety 2020, Vol 5, No 3 3
